SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,444.47 -283.69
( -0.36%)

Global Indices

Nasdaq

53,489.46 -263.95
(-0.49%)

Dow Jones

7,767.06 -39.70
(-0.51%)

Hang Seng

69,148.70 434.90
(0.63%)

Nikkei 225

10,727.81 -22.30
(-0.21%)

Forex

USD-INR

95.39 0.02
(0.02%)

EUR-INR

109.98 -0.03
(-0.03%)

GBP-INR

128.68 -0.13
(-0.10%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

539730

INE194R01017

163.1433353

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

FREDUN

54.09

2403.56

EPS(TTM)

Face Value()

Div & Yield %

26.87

0.02

Date	Headline
05-Aug-2026	Fredun Pharmaceuticals consolidated net profit rises 93.94% in the June 2026 quarter
05-Aug-2026	Fredun Pharmaceuticals surges after Q1 PAT rises 94% YoY to Rs 13 crore
31-Jul-2026	Fredun Pharmaceuticals to convene board meeting
09-Jun-2026	Fredun Pharmaceuticals to convene AGM
29-May-2026	Fredun Pharmaceuticals consolidated net profit rises 79.67% in the March 2026 quarter
25-May-2026	Board of Fredun Pharmaceuticals approves bonus issue of 2:1
25-May-2026	Board of Fredun Pharmaceuticals recommends final dividend
25-May-2026	Fredun Pharmaceuticals standalone net profit rises 56.58% in the March 2026 quarter
16-May-2026	Fredun Pharmaceuticals to announce Quarterly Result
29-Apr-2026	Fredun Pharmaceuticals sets up its 5th manufacturing unit in Palghar

<< < 1 2 > >>

77,444.47 -283.69 ( -0.36%)

53,489.46 -263.95 (-0.49%)

7,767.06 -39.70 (-0.51%)

69,148.70 434.90 (0.63%)

10,727.81 -22.30 (-0.21%)

95.39 0.02 (0.02%)

109.98 -0.03 (-0.03%)

128.68 -0.13 (-0.10%)

0.60 0.00 (-0.03%)